Drug safety has long been an issue however the concern has risen again in recent years following high profile scares. In 2009, FDA reported more than 1,742 recall in comparison to 426 in 2008 and fast pace of drug recalls seems to be continuing in 2010 totalled 296 from January through June of this year1.According to peer-reviewed published studies, FDA-approved prescription drugs injure 2.2 million and kill approximately 100,000 Americans each year and more realistic estimates put the number of deaths at over 200,000 people annually in the United States alone. On the other hand pharmaceutical companies continues to face pressure to develop novel drugs as the patents of many blockbuster drugs are rapidly approaching expiry with at least $150bn worth of blockbuster revenues due to be lost by 20152. Visiongain’s 6th Annual Pharmacovigilance Conference is designed to bring together exclusive panel of experts who will discuss various aspects of pharmacovigilance practices in clinical trails, risk management and drug safety. The conference will feature keynote addresses on reporting, auditing & inspection, technical advances for the betterment of pharmacovigilance practices, live-licensing and pharmacovigilance in Europe, US and Asia.